Introduction
NK cells are spontaneous cytotoxic effectors that kill virusinfected and tumor targets in the absence of prior immunization (1) . Originally, their cytotoxic activity appeared confined to targets that do not express MHC antigens, the so-called 'missing self hypothesis' (2) . Recent data have shown how the cytotoxic potential of NK cells is finely tuned by the action of inhibitory receptors expressed on their surface, specific for MHC class I determinants (3) (4) (5) . In case of absence or alteration in the expression of MHC determinants, the NK activity is released from inhibition and the target cell is killed (6, 7) . Lysis of targets by NK and LAK cells traditionally follows a secretory pathway (8) . Lytic granules present in the cytoplasm of NK and LAK cells are secreted into the intercellular space upon binding to the sensitive target. Granules contain cytotoxic molecules such as membrane active proteins (perforins) (9, 10) and proteases (granzymes) whose activation ultimately leads to DNA damage (11) (12) (13) (14) . This secretory pathway of NK killing eventually leads to the necrosis of the target. Polymerization of perforins into the target cell Correspondence to: M. Vitale Transmitting editor: L. Moretta Received 25 August 1997, accepted 18 December 1997 membrane is likely to produce two effects: (i) the imbalance of the osmotic equilibrium in the target cells and (ii) the entrance of granzyme B into the target cell. In most in vitro assays, the morphological evidence of the effect of the secretory pathway of NK cells is necrosis of the target, due to the action of perforins (15, 16) . Recently, a non-secretory pathway of NK cell killing mediated by Fas-FasL interaction has been described that enables NK cells to kill a variety of tumor targets that are resistant to lysis (reviewed in 17 (25, 26) , as well as upon cross-linking of FcRγIII on their surface (27) . IL-12 is a NK active cytokine (28) that has some important effects on the granzyme B system in NK cells. It has in fact been described as an activator of granzyme B gene transcription (29) . Here, we have studied the induction of apoptosis by unstimulated, and IL-2-and IL-12-stimulated NK cells in NKsensitive Fas -K562 and in NK-insensitive Fas ϩ Raji target cells. Our results show that: (i) morphologically evident apoptosis is higher at low than at high target:effector (T:E) ratios; (ii) fresh peripheral blood lymphocytes (PBL) do not induce significant apoptosis in either targets; (iii) IL-2-stimulated PBL (LAK) induce apoptosis in both targets and the addition of IL-12 to LAK effectors further enhances their apoptotic-inducing capacity; (iv) cytokine-activated cells use both the perforin-granzyme and Fas-FasL pathways to induce apoptosis in target cells; and (v) the Fas pathway is inhibited by the tyrosine kinase inhibitor herbimycin A but not by the protein kinase C (PKC) inhibitor cheleritrin; on the contrary, the granzyme pathway is not blocked by phosphatidylinositol 3-kinase (PI3K), S6 kinase, thymidine kinase (TK), PKC and acidic sphingomyelinase inhibitors.
Methods

Cell cultures
The erythroblastoid cell line K562 and the B lymphoblastoid Raji cells were grown in RPMI 1640 supplemented with 10% FCS and 2 mM L-glutamine. Cells were grown at 37°C in a humidified 5% CO 2 atmosphere. The cell density was maintained between 2ϫ10 5 and 1ϫ10 6 cell/ml.
PBL separation and cytokine treatment
Human peripheral blood mononuclear cells (PBMC) as a source of NK cells were isolated by centrifugation through Ficoll-Hypaque (Sigma, St Louis, MO) gradients. LAK cells were obtained after 48 h culture of non-adherent PBMC in RPMI 1640 medium supplemented with 10% FCS and 2 mM L-glutamine containing 100 U/ml of human recombinant IL-2 (Genzyme, Cambridge, MA). In some experiments, 1 ng/ml of human recombinant IL-12 (Genzyme) was also added for 12 h.
Purified NK cell cultures NK cells were purified from non-adherent PBMC by negative selection. PBL were incubated with anti-CD3 (UCHTI) (a generous gift of Professor A. Moretta, Brescia) and anti-CD4 (Leu-3a) (Becton Dickinson, San Jose, CA) antibodies, and reactive cells were eliminated with goat anti-mouse IgG coated immunomagnetic beads (Dynabeads; Dynal, Oslo, Norway). This last step was performed twice, and the resulting population routinely consisted of Ͼ95% CD3 -, CD4 -and CD56 ϩ lymphocytes.
Purified NK cells were cultured in the presence of irradiated H9 cells and heterologous PBL as feeder cells in RPMI 1640 supplemented with 10% FCS containing 100 U/ml of IL-2 and periodically re-stimulated with irradiated feeder. In some experiments, CD8 -NK cells were purified by negative selection out from the NK cell cultures. Briefly, 5ϫ10 6 purified NK cells were incubated with anti-CD8, washed in PBS and reactive cells were eliminated with goat anti-mouse immunomagnetic beads. Purified CD56 ϩ CD8 -cells were then tested for their apoptosis inducing activity versus purified CD56 ϩ cells.
Chemicals
Wortmannin (PI3K inhibitor), rapamycin (p70 S6 kinase inhibitor), chelerytrine (PKC inhibitor), chloroquine (acidic sphingomyelinase inhibitor) and herbimycin A (TK inhibitor) were purchased from Calbiochem (La Jolla, CA). Stock solutions were prepared in DMSO and stored at -20°C before use. They were used at final concentrations of 100 µM (wortmannin), 10 µg/ml (rapamycin), 1 µM (chelerytrine), 1 mM (chloroquine) and 1 µg/ml (herbimycin A). Control cultures were treated with equal amounts of DMSO alone.
Monensin and EGTA were used at the final concentrations of 1 µM and 2 mM respectively.
Optical microscopy TUNEL reaction was carried out by the in situ cell death detection kit (Boehringer, Mannheim, Germany), according to the manufacturer's indications. Briefly, smears were fixed in 4% paraformaldehyde for 30 min. After blocking of endogenous peroxidase with 0.3% H 2 O 2 in methanol, 50 µl of TUNEL reaction reagent/sample was added. After 60 min of incubation at 37°C, slides were rinsed in PBS, incubated for 30 min at 37°C with 50 µl of converter POD and then exposed to DAB solution (0.5 mg/ml).
Electron microscopy
Cell pellets were fixed with 2% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.2, and post-fixed with 2% OsO 4 . The post-fixed cells were dehydrated in ascending-graded acetone and embedded in Epon 812. Thin sections were stained with methylene blue and observed by optical microscopy. Ultrathin sections were counterstained with uranyl acetate and lead citrate, and examined using a Philips CM10 electron microscope. Effector and target cells were co-cultured in a culture tube for 1-4 h at 37°C at T:E cell ratios of 50-25-10-5-1:1.
In some experiments, targets were incubated with each of the inhibitors listed above for 12 h at the indicated concentration prior to use. Inhibitors were washed away immediately before the cytotoxicity assay. In other experiments, target cells were treated with monensin for 15 h before use and 2 mM EGTA was added to the incubation medium, to block granule exocytosis. Assay were performed in the presence of 2 mM Mg 2ϩ . In some cases, monensin/EGTA-treated effectors were also labeled with blocking anti-FasL mAb (a generous gift of Dr P. Kramer) and the [ 3 H]thymidine retention assay was used to quantify apoptosis, as described (30) .
Results
Target cell apoptosis is induced by cytokine-stimulated PBL PBL were able to induce apoptosis in target cells only if they were previously stimulated with IL-2 ( Fig. 1a and b) , while fresh unstimulated PBL were not able to induce detectable levels of apoptosis in K562 or Raji cells (Fig. 1c) . We found the maximum percentage of apoptotic cells between 3 and 4 h of co-incubation of effectors with targets (Fig. 2a) . Virtually no apoptotic cells were present in the absence of effectors. At a T:E of 1:5, PBL stimulated for 72 h with 100 U/ml IL-2 and overnight with 1 ng/ml IL-12 showed the highest apoptosisinducing activity at all time points considered (Fig. 2a) . On the contrary, IL-2-stimulated PBL (72 h), purified NK cultures and purified NK cultures stimulated overnight with IL-12 showed no significant difference in their apoptosis-inducing activity against K562 cells.
Apoptosis is preferentially generated at low T:E ratios Figure 2(b) shows the percentage of apoptotic K562 target cells generated at different T:E ratios in a 4 h assay. At high T:E ratios most target cells were necrotic after 4 h coincubation with cytokine-stimulated effectors. When the number of effectors was lowered, a progressively increasing number of apoptosis was detected in target cells. The highest number of apoptosis was found between 1:5 and 1:1 T:E ratios. At 1:1 ratio, after 4 h of co-incubation with targets, purified NK cell cultures stimulated overnight with 1 ng/ml IL-12 were the most effective in inducing apoptosis, while no significant difference was observed between purified NK cultures, IL-2-and IL-2 ϩ IL-12-stimulated PBL. Similar kinetics of apoptosis induction were generated in K562 and Raji cells. Figure 3 (a and b) shows the conventional cytotoxicity of stimulated and unstimulated effectors measured by 51 Crrelease assay, under the same conditions as in Fig. 2 . Interestingly, stimulated PBL are most efficient inducers of apoptosis, while cultured NK stimulated with IL-12 are the most efficient inducers of necrosis.
Inhibitors of exocytosis block apoptosis induction in K562
Pretreatment of effectors (both IL-12-stimulated purified NK cultures and IL-2 ϩ IL-12-stimulated PBL) with monensin and EGTA, which prevent granule exocytosis and perforin binding and polymerization (16, 18) , completely blocked the induction of apoptosis in K562 (35.27 Ϯ 5.51 versus 5.4 Ϯ 1.9%) but (Fig. 4) . In both targets, necrosis was completely blocked under these conditions, although many target-effector conjugates were detectable by optical microscopy. Incubation of effectors and targets on ice inhibited both apoptosis and necrosis in both K562 and Raji targets (not shown). On the contrary, pretreatment of target cells with any of the metabolic inhibitors listed in Methods did not inhibit the generation of apoptosis nor alter its kinetics, suggesting that none of the different metabolic pathways they interfere with are crucial to apoptosis-generating activity by cytokine-stimulated NK cells. The non-secretory pathway of apoptosis-induction is blocked by TK and PKC inhibitors Purified NK cell cultures stimulated with IL-12 induce both necrosis and apoptosis in Raji cells. When effectors are pretreated with monensin and EGTA is added, only apoptosis is observed. Figure 5(a and b) shows the expression of Fas on K562 and Raji cells. To demonstrate that apoptosis of Raji cells induced by monensin/EGTA-treated effectors was mediated by Fas-FasL interaction, in some experiments FasL was blocked with a specific blocking mAb. The results shows that when Fas-FasL interaction is blocked, apoptosis is dramatically reduced in Raji cells, while there is a reduction of Ͼ80% of apoptotic Raji cells when the effectors are treated by the combination of monensin/EGTA and blocking anti-FasL mAb (Fig. 6) . Pre-treatment of Raji targets with herbimycin A completely inhibited the induction of apoptosis by monensintreated effectors, indicating that TK play a role in the Fas- In the last group of experiments, CD8 ϩ and CD8 -cytokinestimulated NK cells were evaluated for their apoptosis-inducing activity against K562. No difference was observed in the apoptosis induction activity in K562 or Raji targets by CD8 ϩ versus CD8 -NK cells. Although 40-50% of CD56 ϩ NK cells express CD8 at low density, the number of apoptotic targets was independent of the NK subset used as effector (not shown).
Discussion
Cytotoxic lymphocytes can use more than one system to kill their targets (8) . The best known mechanism is represented by the perforin-mediated secretory pathway. These poreforming proteins make big pores in target cell membrane, ultimately leading to cell necrosis. A second, more recently defined aspect of the secretory pathway is that mediated by granzymes, that apparently enter the target cell through polyperforin pores and activate the caspases, ultimately generating apoptotic cell death of the target (11, 12) . A third, nonsecretory, mechanism of target cell killing used by CTL and cytokine-activated NK cells is represented by the activation of the Fas-FasL pathway (8, 17) . All these lytic mechanisms work in concert, although the physiological conditions in which any of them might be preferentially used instead of the others is still obscure. Although freshly isolated mouse NK cells have been reported to constitutively express low levels of FasL, being therefore able to induce Fas-mediated apoptosis of Fas ϩ targets (18), we did not detect any apoptosis-inducing activity by unstimulated PBL against Fas ϩ Raji target cells. This is in agreement with previously reported data describing the absence of Fas-FasL expression on resting NK cells (8, 32, 33) . On the contrary, cytokine-stimulated PBL induced apoptosis both in Fas ϩ Raji and Fas -K562 target cells. Their apoptosis-inducing activity was particularly effective at low T:E ratios, suggesting that a possible physiological condition in which the apoptotic death pathway might play a major role in NK activity is represented by a numerical prevalence of tumor targets with respect to effectors. However, co-stimulation of IL-2 stimulated PBL with IL-12 or stimulation of purified NK cell cultures with IL-12 always enhanced the generation of apoptosis both in K562 and Raji targets. This is in agreement with the described enhancing effects of IL-12 on the transcriptional rate of granzyme B encoding gene and the consequent accumulation of the protein in the cytoplasmic grains of NK cells (29) . Inhibition of granule exocytosis by monensin, in the presence of Ca 2ϩ chelator EGTA, completely blocked perforin-mediated target cell lysis, as well as apoptosis in K562, as expected, being K562 Fas -. On the contrary, cytokine-stimulated effectors were still able to induce apoptosis in Fas ϩ Raji cells, in the presence of monensin/ EGTA. When FasL was blocked (by a specific blocking antiFasL mAb), stimulated effectors generation of apoptosis in Raji cells was very reduced and virtually abrogated when FasL was blocked in the presence of monensin/EGTA. This result suggests that the Fas pathway of apoptosis induction is always used by FasL ϩ effectors against Fas ϩ targets, possibly in parallel with the secretory pathway.
The various metabolic inhibitors of different signal transduction pathways used in this study did not block the generation of apoptosis in K562 cells. This suggests that neither PI3K nor TK, PKC or sphingomyelin breakdown are required to induce apoptosis through the secretory pathway. On the contrary, the general TK inhibitor herbimycin A partially inhibited apoptosis generated by monensin treated effectors in Raji cells. This is in agreement with the previous studies indicating a role for TK (33, 34) in Fas-mediated apoptotic signaling. Of note, rapamycin did not enhance apoptosis in either target cell. Apparently, therefore, p70 S6 kinase is not part of a pathway that prevents granzyme B-and Fas-induced apoptosis, as demonstrated in different models (35) .
CD56 ϩ CD8 dimϩ cells do not shown a different capacity of apoptosis induction in target cells with respect to their CD56 ϩ CD8 dimϩ counterpart, suggesting that the NK cell population behaves rather homogeneously in the 'choice' of the lytic mechanism.
Our data demonstrate that IL-12 enhances the capacity of IL-2-stimulated NK cells to induce apoptosis in tumor targets cells both via the granzyme and Fas-FasL pathways. The presence of IL-12 at the tumor site, either produced by the tumor itself, like in the case of Epstein-Barr-positive lymphomas, or by phagocytic cells, might therefore not only induce the activation of CD8 ϩ T cells and NK through the production of IFN-γ, but also act on LAK cells as enhancer of their apoptosis-inducing activity against tumor cells.
